These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30519761)

  • 1. ASO Author Reflections: PTTG1 Protein Expression in Adrenocortical Carcinoma.
    Romero Arenas MA; Perrier ND
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):533-534. PubMed ID: 30519761
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
    Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ
    Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target.
    Demeure MJ; Coan KE; Grant CS; Komorowski RA; Stephan E; Sinari S; Mount D; Bussey KJ
    Surgery; 2013 Dec; 154(6):1405-16; discussion 1416. PubMed ID: 24238056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
    Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
    Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas.
    Giordano TJ
    Endocr Pathol; 2006; 17(4):355-63. PubMed ID: 17525484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis and Lymphangiogenesis in the Adrenocortical Tumors.
    Pereira SS; Costa MM; Guerreiro SG; Monteiro MP; Pignatelli D
    Pathol Oncol Res; 2018 Jul; 24(3):689-693. PubMed ID: 28695321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data.
    Tian X; Xu WH; Anwaier A; Wang HK; Wan FN; Cao DL; Luo WJ; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2021 Apr; 25(8):3898-3911. PubMed ID: 33626208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncocytic adrenocortical carcinoma.
    Ohtake H; Kawamura H; Matsuzaki M; Yokoyama E; Kitajima M; Onizuka S; Yamakawa M
    Ann Diagn Pathol; 2010 Jun; 14(3):204-8. PubMed ID: 20471567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature.
    Wanis KN; Kanthan R
    World J Surg Oncol; 2015 Mar; 13():117. PubMed ID: 25889798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?
    Bulzico D; Faria PAS; Maia CB; de Paula MP; Torres DC; Ferreira GM; Pires BRB; Hassan R; Abdelhay E; Vaisman M; Vieira Neto L
    Endocrine; 2017 Nov; 58(2):276-288. PubMed ID: 28887601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of endothelin-1 by adrenocortical carcinoma: a new target for anti-cancer therapy?
    Donckier JE; Michel L; Delos M; Havaux X
    Acta Chir Belg; 2004 Oct; 104(5):581-3. PubMed ID: 15571028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
    Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M
    J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Protein Expression of both
    Brondani VB; Lacombe AMF; Mariani BMP; Montenegro L; Soares IC; Bezerra-Neto JE; Tanno FY; Srougi V; Chambo JL; Mendonca BB; Almeida MQ; Zerbini MCN; Fragoso MCBV
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-fetoprotein (AFP)-producing adrenocortical carcinoma--long survival with various therapeutic strategies including a lung resection: report of a case.
    Hamanaka W; Yoneda S; Shirakusa T; Shirahama H; Tashiro Y; Iwasaki A; Shiraishi T; Tsuru H
    Surg Today; 2008; 38(3):275-8. PubMed ID: 18307006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
    Aronova A; Min IM; Crowley MJP; Panjwani SJ; Finnerty BM; Scognamiglio T; Liu YF; Whitsett TG; Garg S; Demeure MJ; Elemento O; Zarnegar R; Fahey TJ
    Ann Surg Oncol; 2018 Mar; 25(3):792-800. PubMed ID: 29214451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASO Author Reflections: The Impact of Oncocytic Histology on Survival in Adrenocortical Carcinoma.
    Shirali AS; Graham PH
    Ann Surg Oncol; 2022 Sep; 29(9):5564-5565. PubMed ID: 35536522
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adrenocortical tumors with neuroendocrine differentiation].
    Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
    Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study.
    Brown RE; Buryanek J; McGuire MF
    Ann Clin Lab Sci; 2017 Aug; 47(4):457-465. PubMed ID: 28801373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.